Neuland Laboratories- A dedicated 100% API provider.
01 1Neuland Laboratories Limited
01 1Acetyl-Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Lys-OH. Acetate (BIO-11006)
01 1India
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-1016
Start Marketing Date : 2018-10-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
37
PharmaCompass offers a list of BIO-11006 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right BIO-11006 manufacturer or BIO-11006 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred BIO-11006 manufacturer or BIO-11006 supplier.
PharmaCompass also assists you with knowing the BIO-11006 API Price utilized in the formulation of products. BIO-11006 API Price is not always fixed or binding as the BIO-11006 Price is obtained through a variety of data sources. The BIO-11006 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BIO-11006 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BIO-11006, including repackagers and relabelers. The FDA regulates BIO-11006 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BIO-11006 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BIO-11006 supplier is an individual or a company that provides BIO-11006 active pharmaceutical ingredient (API) or BIO-11006 finished formulations upon request. The BIO-11006 suppliers may include BIO-11006 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing BIO-11006 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for BIO-11006 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture BIO-11006 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain BIO-11006 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a BIO-11006 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of BIO-11006 suppliers with NDC on PharmaCompass.
We have 1 companies offering BIO-11006
Get in contact with the supplier of your choice:
